Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/16084
Title: | Fluorine-18 radiolabeling of a nitrophenyl sulfoxide and its evaluation in an SK-RC-52 model of tumor hypoxia | Austin Authors: | Laurens, Evelyn;Yeoh, Shin Dee;Rigopoulos, Angela;O'Keefe, Graeme J;Tochon-Danguy, Henri J ;Chong, Lee Wenn;White, Jonathan M;Scott, Andrew M ;Ackermann, Uwe | Affiliation: | School of Chemistry, The University of Melbourne, Melbourne, Victoria, Australia Bio21 Institute, The University of Melbourne, Melbourne, Victoria, Australia Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia |
Issue Date: | Aug-2016 | Date: | 2016-07-19 | Publication information: | Journal of Labelled Compounds and Radiopharmaceuticals 2016; 59(10): 416-423 | Abstract: | The significance of imaging hypoxia with the positron emission tomography ligand [18 F]FMISO has been demonstrated in a variety of cancers. However, the slow kinetics of [18 F]FMISO require a 2-h delay between tracer administration and patient scanning. Labeled chloroethyl sulfoxides have shown faster kinetics and higher contrast than [18 F]FMISO in a rat model of ischemic stroke. However, these nitrogen mustard analogues are unsuitable for routine production and use in humans. Here, we report on the synthesis and in vitro and in vivo evaluation of a novel sulfoxide, which contains an ester moiety for hydrolysis and subsequent trapping in hypoxic cells. Non-decay corrected yields of radioactivity were 1.18 ± 0.24% (n = 27, 2.5 ± 0.5% decay corrected radiochemical yield) based on K[18 F]F. The radiotracer did not show any defluorination and did not undergo metabolism in an in vitro assay using S9 liver fractions. Imaging studies using an SK-RC-52 tumor model in BALB/c nude mice have revealed that [18 F]1 is retained in hypoxic tumors and has similar hypoxia selectivity to [18 F]FMISO. Because of a three times faster clearance rate than [18 F]FMISO from normoxic tissue, [18 F]1 has emerged as a promising new radiotracer for hypoxia imaging. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/16084 | DOI: | 10.1002/jlcr.3426 | Journal: | Journal of Labelled Compounds and Radiopharmaceuticals | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/27435268 | Type: | Journal Article | Subjects: | SK-RC-52 tumor model Hypoxia Radiolabelling Small animal imaging |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.